Search

Searching with a thematic focus on Corporate Social Responsibility, Trade Policy, Intellectual Property Rights

Showing 11-20 of 20 results

Pages

• Document

  What is biopiracy?

  Institute of Education, University of London, 2004

  This paper seeks to shed some light on the meaning of the term “biopiracy” and to consider what should be done about it, bearing in mind that agreement on what is and isn’t biopiracy, and how much of it there actually is, is lacking. The fact that patent claims in various countries may incorporate biological and genetic material within their scope combined with the belief - held by many develop
• Document

  Ownership of knowledge: the role of patents in pharmaceutical R&D

  Bulletin of the World Health Organization : the International Journal of Public Health, 2004

  This very short paper gives an overview of the role of patents in pharmaceutical R&D. As this paper points out, government funding for R&D has experienced a sharp decline in almost all industrialised countries since the 1980’s. As a result of that the private sector has gained much more importance.
• Document

  Robbing the poor to pay the rich? How the United States keeps medicines from the world’s poorest

  Oxfam, 2003

  Much suffering and death could be prevented if people had regular access to medicines, yet one-third of the world’s population does not. Many factors are responsible, including poverty, lack of finance, and poor health service infrastructure – but the high cost of new patented medicines is also a key factor.
• Document

  Intellectual and cultural property rights of Indigenous and Tribal Peoples in Asia

  Minority Rights Group International, 2003

  This report looks at efforts by the UN and governments to protect indigenous and tribal heritage from exploitation; the pressures on governments to allow exploitation of indigenous knowledge; the many initiatives taken by Asian indigenous and tribal peoples to protect their heritage; and the effects of the General Agreement on Tariffs and Trade (GATT) and the Trade-Related Aspects of International
• Document

  Fair Trade: a balance of intellectual property, competition and other rights

  Interamerican Association of Industrial Property, 2003

  This paper presents recommendations for the WTO 5th Ministerial Conference in Cancún on the following subjects:dispute settlement understandingantitrustcorporate governance: trade and investmenttrade and environmenttrade and transfer of technologybiological resources, folklore and traditional knowledgegeographical indicationsdeclaration on the TRIPs agreement an
• Document

  Trade for life: making trade work for poor people

  Christian Aid, 2001

  This report assesses the global trade rules and asks how they can be rewritten in order to benefit poor people.The paper argues that trade should not be driven by a theoretical model whose impact on poor people, they claim, is at best irrelevant and at worst damaging.
• Document

  Beyond philanthropy: the pharmaceutical industry, corporate social responsibility and the developing world

  Save the Children Fund, 2002

  This paper argues that responsible pharmaceutical companies must have policies on access to treatment for developing countries which include the five priorities of: pricing; patents; joint public private initiatives (JPPIs); research and development (R&D); and the appropriate use of drugs.
• Document

  Alternatives for the Americas

  Global Exchange, 1998

  an international effort to create positive alternatives to the neoliberal model imposed from above by international capital.The document addresses the major topics on the official agenda of the Free Trade Area of the Americas (FTAA) negotiators (investment, finance, intellectual property rights, agriculture, market access and dispute resolution), as well as topics that are of extreme social im
• Document

  Dare to lead: public health and company wealth

  Oxfam, 2001

  This is the first in a series of briefing papers analysing the human development impact of transnational corporations (TNCs).
• Document

  Report of the workshop on differential pricing and financing of essential drugs

  World Trade Organization, 2001

  Differential pricing could, and should, play an important role in ensuring access to existing essential drugs at affordable prices, especially in poor countries, while allowing the patent system to continue to play its role of providing incentives for research and development into new drugs.

Pages